Activation of silent biosynthetic gene clusters and profiling of secondary metabolites secreted by Endophytic Fungi for use as potential anti-HIV agents.
Year: 2022
Type: dissertation
Abstract: The continuous burden of Human Immunodeficiency Virus-1 in Sub-Saharan Africa, coupled \nwith the inability of antiretroviral agents to eradicate HIV-1 from viral reservoirs, the potential \nrisks of drug resistance development, and the development of adverse effects, emphasizes the \nneed to develop a new class of HIV-1 inhibitors. Here, we cultivated five endophytic fungi \nisolated from Albizia adianthifolia with the addition of small epigenetic modifiers, sodium \nbutyrate and valproic acid, to induce the expression of biosynthetic gene clusters encoding \nactive secondary metabolites with probable anti-HIV activities. We identified a non-toxic crude \nextract of the endophytic fungus Penicillium chrysogenum treated with sodium butyrate to \npossess significantly greater anti-HIV activity than the untreated extracts. Single-round \nfractionated extracts of treated P.chrysogenum showed potent anti-HIV activity with an IC₅₀ of \n5.90 μg/mL and a 5-fold increase compared to the untreated fraction. The active fractionated \nextracts were subjected to gas chromatography-mass spectrometry (GCMS), and more \nbioactive compounds were detected in treated P.chrysogenum fractions than in untreated \nfractions. These results indicate that treatment of endophytic fungi with small epigenetic \nmodifiers enhances the secretion of secondary metabolites with anti-HIV-1 properties, \nacknowledging the feasibility of epigenetic modification as an innovative approach for the \ndiscovery of cryptic fungal metabolites as therapeutic compounds
Author: Makhwitine, John Phuti.
Institution: University of KwaZulu-Natal
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7064040533
